title: Mid-dermal elastolysis: another dermatological clue to autoimmunity?
authors.affiliation: Department of Dermatology, Hospital del Mar, Parc de Salut Mar, Institut Municipal d’Investigació Mèdica, ES-08003 Barcelona, Spain.
authors.forename: María Estela
authors.initials: ME
authors.lastname: Martínez-Escala
authors.forename: Eduardo
authors.initials: E
authors.lastname: Rozas
authors.forename: Ramon M
authors.initials: RM
authors.lastname: Pujol
authors.forename: Josep Eugeni
authors.initials: JE
authors.lastname: Herrero-González
mesh_terms: D000328:Adult; D000974:Antibodies, Antinuclear / Q000097:blood; D017152:Antibodies, Antiphospholipid / Q000097:blood; D015551:Autoimmunity; D001706:Biopsy; D003483:Cutis Laxa / Q000097:blood / Q000188:drug therapy / Q000276:immunology* / Q000473:pathology; D003879:Dermatologic Agents / Q000627:therapeutic use; D004547:Elastic Tissue / Q000187:drug effects / Q000276:immunology* / Q000473:pathology; D005260:Female; D006801:Humans; D006886:Hydroxychloroquine / Q000627:therapeutic use; D007515:Islets of Langerhans / Q000276:immunology; D012867:Skin / Q000187:drug effects / Q000276:immunology* / Q000473:pathology; D016896:Treatment Outcome
chemical_list: D000974:Antibodies, Antinuclear; D017152:Antibodies, Antiphospholipid; D003879:Dermatologic Agents; D006886:Hydroxychloroquine